On this page:
Bladder cancer is the 7th commonest cancer in the UK with 10,000 new diagnoses and 5,000 deaths from bladder cancer every year. Bladder cancer is usually identified during investigations for blood in the urine (haematuria) and is treatable in the majority of the cases.
We run one-stop rapid access haematuria clinics weekly where patients can have an ultrasound examination of the urinary tracts and a flexible cystoscopy (bladder inspection with a thin flexible telescope) on the same day.
Patients with invasive bladder cancer or recurrent non-muscle invasive bladder cancer may be offered radical cystectomy. This is performed using the da Vinci® robotic system which forms the next step from keyhole surgery (laparoscopic surgery). The system allows the surgeon to use miniaturised instruments through small incisions to remove the bladder and surrounding tissue – the technique allows for quicker recovery and reduced pain following the operation.
We offer the following investigations and treatments for bladder cancer:
- Cystoscopy (including Narrow Band Imaging (NBI))
- Transurethral resection of bladder tumour delivered by consultants with interest in bladder cancer
- Intravesical chemotherapy/immunotherapy (bladder instillation with Mitomycin C or BCG)
- Hyperthemic Chemotherapy service which is the largest and the most established service in the UK to treat high risk bladder cancer which has not breached to the bladder muscle but is resistant to standard therapies.
Chris Backhouse, Cancer Nurse Specialist
- 020 8725 0393
Deepa Leelamany, Urology Clinical Nurse Specialist Service Lead
- 020 8725 1752
Laura Powell, Cancer Nurse Specialist
- 020 8725 4124
Contact: Louise Fitzgerald
- 020 8725 3364